Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation

Opportunistic infections contribute to morbidity and mortality of patients Undergoing hematopoietic stein cell transplantation and treatment for malignancies. Rothia mucilaginosa, a gram-positive bacterium, is responsible for rare, but often fatal meningitis in severely immunocomprornised patients. We describe two cases of meningitis from discrete strains of R. mucilaginosa on Our pediatric bone marrow transplant unit, summarize the published cases of R. mucilaginosa meningitis in oncology and stein cell transplant patients, and provide updated recommendations regarding the use of antibiotic therapy in this patient population.